Pharmafile Logo
Pharmafocus logo
Advanced Search

GSK pledges further trial transparency

March 26, 2009
Research and Development, Sales and Marketing GSK

GlaxoSmithKline is to make its clinical trials more transparent through a series of moves it believes will facilitate clinical research. …

News

NICE recommends Pfizer’s Sutent

March 26, 2009
Research and Development NICE, Pfizer, Sutent

NICE has issued its final guidance on Pfizer's Sutent, recommending the kidney cancer drug as a first-line treatment. The drug …

News

GSK linked to Allergan takeover

March 26, 2009
Sales and Marketing Allergan, GSK

GlaxoSmithKline may be considering a bid to buy Allergan, the company behind 'cosmaceutical' products such as Botox. Analysts have seized …

News

Grand Designs

March 25, 2009
Sales and Marketing NHS, healthcare, outcomes, patient, pharma

Feature

Small and flexible: the manufacturing of tomorrow

March 24, 2009
Manufacturing and Production biologics

Biopharmaceutical manufacturing is likely to undergo a dramatic change over the next 20 years, with the today's facilities facing dramatic …

News

GlaxoSmithKline and UCL to develop biologic

March 24, 2009
Research and Development GSK

Researchers at University College London are to work with GlaxoSmithKline to develop a new treatment for the rare and often …

News

Merck Serono sets up biotech fund

March 24, 2009
Research and Development Merck Serono, biotech

Merck Serono has set up a venture capital fund to invest in emerging biotech companies working in its core therapy …

News

Survey adds pressure for re-think on bowel cancer drugs

March 24, 2009
Medical Communications, Sales and Marketing Cancer

A new survey by Beating Bowel Cancer has highlighted the problems facing patients with the condition in getting the best …

News

Biosimilars: time for an approval pathway in the US

March 23, 2009
Research and Development, Sales and Marketing US, generics

Congress has received another bill seeking to establish a biosimilars approval pathway in the US. HR 1427 represents the latest …

News

Big pharma is a ‘broken model’

March 23, 2009
Manufacturing and Production Burrill

News

Bayer strikes R&D deal with Chinese university

March 20, 2009
Research and Development Bayer, China, academic research

 Bayer has furthered its R&D expansion in China with an agreement to form a joint pharmaceutical research centre with Tsinghua …

News

Lundbeck launches sleep awareness campaign

March 20, 2009
Sales and Marketing Lundbeck, sleep

Lundbeck has launched a campaign aiming to raise awareness of insomnia and sleep problems. 'Sleep well, Live well ' is …

News

Shire withdraws ADHD patch filing

March 19, 2009
Research and Development, Sales and Marketing Shire

Shire has withdrawn the European marketing application for its Attention Deficit Hyperactivity Disorder (ADHD) patch product Daytrana. The product's active …

News

Sanofi boosted by Multaq vote of approval

March 19, 2009
Research and Development, Sales and Marketing FDA, Multaq, Sanofi, US

An FDA committee has recommended Sanofi-Aventis' new atrial fibrillation treatment Multaq, the company's most important late-stage drug. The FDA cardiovascular …

News

FDA to review Xarelto safety concerns

March 19, 2009
Research and Development, Sales and Marketing Xarelto

Anti-blood clotting drug Xarelto could fail to win approval in the US due to safety concerns. The FDA has convened …

News

ProStrakan ‘on target’ to break-even this year

March 19, 2009
Sales and Marketing ProStrakan

ProStrakan says it will move into the black later this year, after sales rose by a third and its operating …

News

Biosimilars bill offers 12 years’ marketing exclusivity

March 19, 2009
Research and Development US, generics

The US moved one step closer to creating a market for biosimilars – substitutable versions of branded biologic drugs – …

News

Hamburg appointed as new FDA head

March 18, 2009
Research and Development FDA

A leading public health expert has been appointed as the new head of the FDA. President Obama has selected Dr …

News

Patent office shows tougher stance on “evergreening”

March 18, 2009
Research and Development Europe

The rate of patent applications refused in Europe has risen to an all time high, as authorities target "evergreening" of …

News

Getting the most out of your product portfolio

March 17, 2009
Research and Development, Sales and Marketing portfolio, product

Portfolio planning should be a practical process that delivers a programme of work to take you to sunnier shores. All …

Feature
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025